The United States announced that it will stop funding programmes in South Africa intended to combat HIV and AIDS. The decision was backed by the State Department’s statement that South Africa has not demonstrated adequate policy changes to continue receiving aid.
Historically the U.S. provided about $400m a year through the President’s Emergency Fund for AIDS Relief (PEPFAR), a funding stream that covered roughly a fifth of South Africa’s HIV response budget. A short‑term “bridge plan” extended the support into 2025, but the upcoming phased drawdown will cut this significant source of finance.
South Africa’s health ministry replied that while it had not been informed of the decision, the country has been developing a self‑reliance plan and that antiretroviral drug procurement is largely government‑funded.
The funding cut comes against a backdrop of increasingly tense U.S.–South African relations. President Trump’s 2025 executive order accused South Africa of dismantling equal opportunities and fostering racial discrimination, claiming a “white genocide.” The U.S. also boycotted the G20 meeting hosted in Johannesburg.
The loss of PEPFAR funding threatens to hamper South Africa’s efforts to address its status as the country with the largest HIV population in the world. As the government moves forward, the impact on treatment programmes and public health infrastructure remains a critical concern.
